UCB - Passività Correnti





Passività Correnti Cambiamento Data
Alcon AG USD 3.17B 163M 2026-06
Almirall EUR 323.65M 26.99M 2026-06
Amarin USD 175.14M 10.94M 2026-09
argenx SE USD 1.58B 254.81M 2026-06
AstraZeneca USD 31.27B 286M 2026-09
Bayer EUR 29.4B 2.87B 2026-09
Genmab DKK 1.14B 38M 2026-06
GlaxoSmithKline GBP 20.72B 814M 2026-09
GRIFOLS EUR 2.3B 59M 2026-09
Hikma Pharmaceutical USD 1.45B 603M 2025-12
Lakefront Biotherapeutics EUR 70.32M 30.1M 2026-06
Lonza CHF 3.57B 421M 2025-12
Merck EUR 8.96B 833M 2026-09
Novartis USD 32.52B 777M 2026-09
Orion EUR 491.8M 37.3M 2026-09
Recordati EUR 1.4B 4.3M 2026-09
Roche Holding CHF 28.85B 846M 2026-06
Sanofi EUR 29.77B 2.16B 2026-09
UCB EUR 4.4B 470M 2025-12
Unibail Rodamco EUR 3.13B 2.32B 2025-12